Literature DB >> 6820735

Immunological aspects of Behçet's and Vogt-Koyanagi-Harada's diseases.

S Ohno.   

Abstract

Immunogenetic studies showed that Behçet's disease has a primary association with HLA-B antigen (HLA-BW51) and the same association throughout the world, whereas, Vogt-Koyanagi-Harada's disease (VKH) is primarily associated with supertypic HLA-DR antigen (MT3), an HLA-D-linked B cell alloantigen in Japanese. Immunological investigation showed that the serum levels of gamma-interferon (IFN-gamma) were significantly increased in both Behçet's disease and VKH, IFN-gamma showed a significant decrease in the ocular exacerbation stage in Behçet's disease. The highest IFN titre was observed 1 to 2 months after the onset of the disease in VKH.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6820735

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN: 0078-5334


  18 in total

Review 1.  The natural history of uveitis.

Authors:  R B Nussenblatt
Journal:  Int Ophthalmol       Date:  1990-10       Impact factor: 2.031

2.  Natural killer cells in Behçet's disease.

Authors:  K Hamzaoui; K Ayed; M Hamza; J L Touraine
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

3.  High incidence of glucose intolerance in Vogt-Koyanagi-Harada disease.

Authors:  N Yawata; S Nakamura; M Kijima; N Ikai; M Kanai; M Sugita; S Ohno
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

4.  High prevalence of angle-closure glaucoma in Vogt-Koyanagi-Harada disease.

Authors:  Carlos Alvarez-Guzman; Jorge E Valdez-Garcia; Raul E Ruiz-Lozano; Alejandro Rodriguez-Garcia; Carlos F Navas-Villar; Curt Hartleben-Matkin; Miguel Pedroza-Seres
Journal:  Int Ophthalmol       Date:  2022-07-05       Impact factor: 2.031

5.  Cyclosporin in Behçet's disease: results in 16 patients after 24 months of therapy.

Authors:  M L Pacor; D Biasi; C Lunardi; P Cortina; P Caramaschi; D Girelli; M Botto; G Urbani; G Lombardo; L M Bambara
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

6.  Vogt-Koyanagi-Harada syndrome, a rare association of Hodgkin's disease.

Authors:  S Y Chuah; A J Lyne; M W Dronfield
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

7.  Tuberculin skin-test-induced uveitis in the absence of tuberculosis.

Authors:  C F Burgoyne; T C Verstraeten; T R Friberg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

8.  Vogt-Koyanagi-Harada syndrome associated with cutaneous malignant melanoma: an 11-year follow-up.

Authors:  Sabine Aisenbrey; Christoph Lüke; Helen D Ayertey; Salvatore Grisanti; Andreas Perniok; Richard Brunner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-11-14       Impact factor: 3.117

9.  Relative changes in luminal and stromal areas of choroid determined by binarization of EDI-OCT images in eyes with Vogt-Koyanagi-Harada disease after treatment.

Authors:  Hiroki Kawano; Shozo Sonoda; Takehiro Yamashita; Ichiro Maruko; Tomohiro Iida; Taiji Sakamoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-02-04       Impact factor: 3.117

10.  HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410.

Authors:  Y Shindo; H Inoko; T Yamamoto; S Ohno
Journal:  Br J Ophthalmol       Date:  1994-03       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.